Personal tools

MCL coexpression mm9:361: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0010314!8.17e-20!92;UBERON:0002346!1.61e-19!64;UBERON:0003075!1.61e-19!64;UBERON:0007284!1.61e-19!64;UBERON:0010371!7.26e-18!73;UBERON:0004121!6.06e-17!95;UBERON:0000924!6.06e-17!95;UBERON:0006601!6.06e-17!95;UBERON:0000073!1.05e-16!54;UBERON:0001017!1.91e-16!73;UBERON:0001016!4.55e-16!75;UBERON:0003056!1.22e-15!49;UBERON:0001049!1.36e-15!52;UBERON:0005068!1.36e-15!52;UBERON:0006241!1.36e-15!52;UBERON:0007135!1.36e-15!52;UBERON:0000955!7.10e-14!47;UBERON:0006238!7.10e-14!47;UBERON:0002616!2.59e-13!46;UBERON:0003080!2.60e-12!40;UBERON:0002780!1.13e-11!39;UBERON:0001890!1.13e-11!39;UBERON:0006240!1.13e-11!39;UBERON:0000468!8.88e-11!333;UBERON:0002020!2.99e-10!34;UBERON:0000025!3.28e-10!114;UBERON:0004111!7.62e-10!122;UBERON:0003528!9.65e-09!29;UBERON:0002791!9.65e-09!29;UBERON:0001893!9.65e-09!29;UBERON:0000922!2.60e-08!320;UBERON:0002021!1.96e-07!10;UBERON:0000411!1.96e-07!10;UBERON:0001950!1.96e-07!10
|ontology_enrichment_uberon=UBERON:0010314!8.17e-20!92;UBERON:0002346!1.61e-19!64;UBERON:0003075!1.61e-19!64;UBERON:0007284!1.61e-19!64;UBERON:0010371!7.26e-18!73;UBERON:0004121!6.06e-17!95;UBERON:0000924!6.06e-17!95;UBERON:0006601!6.06e-17!95;UBERON:0000073!1.05e-16!54;UBERON:0001017!1.91e-16!73;UBERON:0001016!4.55e-16!75;UBERON:0003056!1.22e-15!49;UBERON:0001049!1.36e-15!52;UBERON:0005068!1.36e-15!52;UBERON:0006241!1.36e-15!52;UBERON:0007135!1.36e-15!52;UBERON:0000955!7.10e-14!47;UBERON:0006238!7.10e-14!47;UBERON:0002616!2.59e-13!46;UBERON:0003080!2.60e-12!40;UBERON:0002780!1.13e-11!39;UBERON:0001890!1.13e-11!39;UBERON:0006240!1.13e-11!39;UBERON:0000468!8.88e-11!333;UBERON:0002020!2.99e-10!34;UBERON:0000025!3.28e-10!114;UBERON:0004111!7.62e-10!122;UBERON:0003528!9.65e-09!29;UBERON:0002791!9.65e-09!29;UBERON:0001893!9.65e-09!29;UBERON:0000922!2.60e-08!320;UBERON:0002021!1.96e-07!10;UBERON:0000411!1.96e-07!10;UBERON:0001950!1.96e-07!10
|tfbs_overrepresentation_for_novel_motifs=0.379825,0.859739,0.341317,0.144583,0.191527,0.15366,0.615468,0.436916,0.247005,1.84849,1.0366,0.595264,1.04792,0.223743,0.0582501,0,0.977447,0.182139,0.0794196,0.726362,0.0854539,0.710085,0.63467,1.13786,0.352326,0.243873,0.188741,0.167184,0.248458,0.443023,0.477864,0.460285,1.09732,0.315369,0.464943,1.06049,0.680806,0.2039,0.144722,1.62221,0.0498798,0.942805,0.0801319,0.214332,1.20376,0.843029,0.833552,0.52593,0.0553373,0.252327,0.359925,0.729809,0.417327,0.586014,1.46504,0.22892,0.559359,0.573993,0.173818,1.20474,0.442975,0.271204,0.269556,0.92519,1.2413,0.384144,0.727642,1.06142,0.438956,0.919268,2.18032,0.0223673,1.3274,0.632466,0.830159,0.769781,0.808662,0.300684,0.428247,0.0875778,0.0226705,0.388829,0.743757,0.217876,1.3095,0.764782,0.211214,0.122924,1.52233,1.21975,0.793151,0.532634,0.471416,0.053818,2.87942,0.0296941,0.224978,1.19351,0.309859,1.14352,0.0440835,0.460042,0.570262,0.946715,0.359547,0.941628,0.409409,0.519389,1.55184,1.02158,0.369309,0.57187,0.0881503,0.187937,0.799811,0.184628,1.9099,0.882315,0.375433,0.164609,0.637418,0.333667,1.27213,1.47357,0.851175,0.43141,0.220786,0.465518,0.726225,0.446029,0.554981,0.432886,0.698665,1.93628,0.820264,0.0929961,0.392468,0.162291,0.773792,1.58317,1.18855,0.732048,0.254204,0.469382,0.933035,0.944018,0.31213,1.54387,0.125637,0.429877,0.126282,5.45486,0.587436,0.30395,0.238221,0.662158,0.264789,0.0633954,0.117954,3.2201,0.782756,0.527439,1.10281,0.365959,0.351524,0.232792,0.167532,1.11929,0.0368447
}}
}}

Revision as of 18:14, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr14:12385975..12385998,+p4@Ptprg
Mm9::chr14:12386013..12386028,+p6@Ptprg
Mm9::chr18:35862724..35862735,-p3@Dnajc18
Mm9::chr18:35862738..35862753,-p1@Dnajc18
Mm9::chr18:38761259..38761273,+p2@Arhgap26
Mm9::chr18:64676201..64676219,-p2@Nars
Mm9::chr19:45438234..45438321,+p1@Btrc
Mm9::chr2:116946596..116946618,+p2@Spred1
Mm9::chr2:116946787..116946885,+p1@Spred1
Mm9::chr2:121692654..121692733,+p1@Casc4
Mm9::chr2:80421372..80421385,-p5@Nckap1
Mm9::chr2:80421391..80421423,-p2@Nckap1
Mm9::chr2:80421429..80421450,-p3@Nckap1
Mm9::chr3:63780031..63780057,+p2@Gmps
Mm9::chr7:25039763..25039831,+p1@Zfp108
Mm9::chr7:99890142..99890225,+p1@Rab30
Mm9::chrX:108810678..108810736,-p1@Hdx
Mm9::chrX:131252469..131252480,+p2@Armcx1
Mm9::chrX:131252482..131252557,+p1@Armcx1
Mm9::chrX:133275818..133275846,-p1@Morf4l2
Mm9::chrX:72341224..72341261,+p2@Dkc1
Mm9::chrX:92906980..92907024,+p2@Zc3h12b


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0016836hydro-lyase activity0.030392264285323
GO:0045175basal protein localization0.030392264285323
GO:0030950establishment and/or maintenance of actin cytoskeleton polarity0.030392264285323
GO:0003922GMP synthase (glutamine-hydrolyzing) activity0.030392264285323
GO:0003921GMP synthase activity0.030392264285323
GO:0032879regulation of localization0.030392264285323
GO:0030952establishment and/or maintenance of cytoskeleton polarity0.030392264285323
GO:0032880regulation of protein localization0.030392264285323
GO:0016835carbon-oxygen lyase activity0.0321103085972842
GO:0007509mesoderm migration0.037392542559238
GO:0008078mesodermal cell migration0.037392542559238
GO:0007354zygotic determination of anterior/posterior axis, embryo0.037392542559238
GO:0006421asparaginyl-tRNA aminoacylation0.037392542559238
GO:0016874ligase activity0.0391467307563428
GO:0005173stem cell factor receptor binding0.0418606881635714
GO:0006177GMP biosynthetic process0.0418606881635714
GO:0006399tRNA metabolic process0.0418606881635714
GO:0048570notochord morphogenesis0.0418606881635714
GO:0046037GMP metabolic process0.0418606881635714
GO:0048617embryonic foregut morphogenesis0.0418606881635714
GO:0010172embryonic body morphogenesis0.0418606881635714
GO:0000154rRNA modification0.0418606881635714
GO:0030519snoRNP binding0.0418606881635714
GO:0007440foregut morphogenesis0.0418606881635714
GO:0000578embryonic axis specification0.0418606881635714
GO:0031119tRNA pseudouridine synthesis0.0418606881635714
GO:0008595determination of anterior/posterior axis, embryo0.0418606881635714
GO:0010171body morphogenesis0.0418606881635714
GO:0007351tripartite regional subdivision0.0418606881635714
GO:0007350blastoderm segmentation0.0440654891570662
GO:0048611embryonic ectodermal gut development0.0440654891570662
GO:0048613embryonic ectodermal gut morphogenesis0.0440654891570662
GO:0006400tRNA modification0.0440654891570662
GO:0030903notochord development0.0440654891570662
GO:0045176apical protein localization0.0440654891570662
GO:0016829lyase activity0.0440654891570662
GO:0042074cell migration involved in gastrulation0.0440654891570662
GO:0050821protein stabilization0.0440654891570662
GO:0048558embryonic gut morphogenesis0.0440654891570662
GO:0016884carbon-nitrogen ligase activity, with glutamine as amido-N-donor0.0440654891570662
GO:0004730pseudouridylate synthase activity0.0440654891570662
GO:0016879ligase activity, forming carbon-nitrogen bonds0.0440654891570662
GO:0043170macromolecule metabolic process0.0440654891570662
GO:0048340paraxial mesoderm morphogenesis0.0440654891570662
GO:0000188inactivation of MAPK activity0.0440654891570662
GO:0031647regulation of protein stability0.0440654891570662
GO:0001522pseudouridine synthesis0.0440654891570662
GO:0048557embryonic digestive tract morphogenesis0.0440654891570662
GO:0008105asymmetric protein localization0.0440654891570662
GO:0044238primary metabolic process0.0440654891570662
GO:0044237cellular metabolic process0.0440654891570662
GO:0007439ectodermal gut development0.0440654891570662
GO:0009168purine ribonucleoside monophosphate biosynthetic process0.0440654891570662
GO:0009127purine nucleoside monophosphate biosynthetic process0.0440654891570662
GO:0048567ectodermal gut morphogenesis0.0440654891570662
GO:0048547gut morphogenesis0.0451697183144582
GO:0009167purine ribonucleoside monophosphate metabolic process0.0451697183144582
GO:0009126purine nucleoside monophosphate metabolic process0.0451697183144582
GO:0009948anterior/posterior axis specification0.0451697183144582
GO:0048546digestive tract morphogenesis0.0491768801296322
GO:0048339paraxial mesoderm development0.0491768801296322
GO:0035050embryonic heart tube development0.0491768801296322
GO:0048566embryonic gut development0.0491768801296322
GO:0009156ribonucleoside monophosphate biosynthetic process0.0491768801296322



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
structure with developmental contribution from neural crest8.17e-2092
neurectoderm1.61e-1964
neural plate1.61e-1964
presumptive neural plate1.61e-1964
ecto-epithelium7.26e-1873
ectoderm-derived structure6.06e-1795
ectoderm6.06e-1795
presumptive ectoderm6.06e-1795
regional part of nervous system1.05e-1654
central nervous system1.91e-1673
nervous system4.55e-1675
pre-chordal neural plate1.22e-1549
neural tube1.36e-1552
neural rod1.36e-1552
future spinal cord1.36e-1552
neural keel1.36e-1552
brain7.10e-1447
future brain7.10e-1447
regional part of brain2.59e-1346
anterior neural tube2.60e-1240
regional part of forebrain1.13e-1139
forebrain1.13e-1139
future forebrain1.13e-1139
multi-cellular organism8.88e-11333
gray matter2.99e-1034
tube3.28e-10114
anatomical conduit7.62e-10122
brain grey matter9.65e-0929
regional part of telencephalon9.65e-0929
telencephalon9.65e-0929
embryo2.60e-08320
occipital lobe1.96e-0710
visual cortex1.96e-0710
neocortex1.96e-0710


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:361&oldid=2561581"